Weston, Brian R <br/><br/>
Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy: how soon should we repeat endoscopic retrograde cholangiopancreatography?  [electronic resource] 

 -  Cancer  Jun 2008 
 - 2417-23 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1097-0142 
<br/><br/><label>Standard No.: </label>10.1002/cncr.23454  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--blood<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Bilirubin--blood<br/>Cholangiocarcinoma--blood<br/>Cholangiopancreatography, Endoscopic Retrograde<br/>Cholestasis--etiology<br/>Female<br/>Gallbladder Neoplasms--blood<br/>Humans<br/>Liver Neoplasms--secondary<br/>Male<br/>Middle Aged<br/>Pancreatic Neoplasms--blood<br/>Prognosis<br/>Retrospective Studies<br/>Stents